<DOC>
	<DOCNO>NCT01130766</DOCNO>
	<brief_summary>The prognosis NSCLC patient asymptomatic brain metastasis , treat SRS WBRT fully investigate yet . This randomized phase III trial conduct determine exact role SRS NSCLC patient asymptomatic oligo brain metastasis whether early treatment SRS would improve survival even patient asymptomatic brain metastasis .</brief_summary>
	<brief_title>Asymptomatic Brain Metastasis Non-small Cell Lung Cancer ( NSCLC )</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>Histologically confirm nonsmall cell lung cancer synchronous brain metastasis ( diagnosis brain lesion within 2 month diagnosis primary site tumor ) One 4 intraparenchymal brain metastasis contrastenhanced MRI , meet follow criterion : 1 . Well circumscribed tumor ( ) brain edema Grade 01 2 . Maximum diameter ≤ 3.0 cm No prior complete resection know brain metastasis RT ④ No leptomeningeal metastases MRI cerebrospinal fluid evaluation Patients without symptom sign brain metastasis ( RTOG neurologic function status 0 ) ⑥ Age , 18 ⑦ ECOG performance status 01 ⑧ Written inform consent severe comorbid illness and/or active infection ② pregnant lactate woman RTOG neurologic function status 1~4 ④ Uncontrollable extracranial metastasis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Non-small Cell Lung Cancer</keyword>
	<keyword>Asymptomatic brain metastasis</keyword>
	<keyword>Stereotactic radiosurgery ( SRS )</keyword>
</DOC>